NCT03820089

Brief Summary

Many women suffers from uterine and vaginal prolapse Usually they suffer from these symotoms in menopause

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

January 29, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2020

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2020

Completed
Last Updated

February 10, 2022

Status Verified

January 1, 2022

Enrollment Period

12 months

First QC Date

January 25, 2019

Last Update Submit

January 27, 2022

Conditions

Prolapse

Outcome Measures

Primary Outcomes (1)

  • The number of women who will be properly diagnosed with prolapse by TP us

    The accuracy of TP US in diagnosing the prolapse

    within 2 months

Interventions

Ultrasonography TPDIAGNOSTIC_TEST

TP us will be made to the included women

Eligibility Criteria

Age25 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales who have pelvic organ prolapse
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women who complains from genital prolapse with previous normal deliveries

You may qualify if:

  • Women with history of normal delivery Age between 25 to 75 years

You may not qualify if:

  • women with cesarean deliveries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

Location

MeSH Terms

Conditions

Prolapse

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy, PhD

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
8 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2019

First Posted

January 29, 2019

Study Start

January 29, 2019

Primary Completion

January 20, 2020

Study Completion

January 25, 2020

Last Updated

February 10, 2022

Record last verified: 2022-01

Locations

EG(1)